Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Hong

Showing results (161-170 of 442) with videos related to

Pageof 45
Sort By:
Cancer Chemotherapy and Pharmacology|March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesSiqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
American Journal of Surgery|November 21, 2021
Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical centerRachel E Sargent, Elizabeth Vazquez, Irene Kang, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2016
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancerRabih Said, Eugenia Kakadiaris, Sarina Piha-Paul, et al.
Archives of Dermatology|June 19, 2008
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnibDavid S Hong, Srini B Reddy, Victor G Prieto, et al.
Oncotarget|April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimusSarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.
Plos One|June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitorsIgnacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Molecular Cancer Therapeutics|May 17, 2011
Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activitySiqing Fu, Aung Naing, Stacy L Moulder, et al.
Pageof 45

Showing results (161-170 of 442) with videos related to

Sort By:
Pageof 45
Cancer Chemotherapy and Pharmacology|March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesSiqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
American Journal of Surgery|November 21, 2021
Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical centerRachel E Sargent, Elizabeth Vazquez, Irene Kang, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2016
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancerRabih Said, Eugenia Kakadiaris, Sarina Piha-Paul, et al.
Archives of Dermatology|June 19, 2008
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnibDavid S Hong, Srini B Reddy, Victor G Prieto, et al.
Oncotarget|April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimusSarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.
Plos One|June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitorsIgnacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Molecular Cancer Therapeutics|May 17, 2011
Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activitySiqing Fu, Aung Naing, Stacy L Moulder, et al.
Pageof 45